A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate-to-Severe Alopecia Areata

Clinical trial NCT05205070 · UNKNOWN

Trial details

NCT number: NCT05205070
Sponsor: AnaptysBio, Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Alopecia Areata

Start date: 2021-12-22
Primary completion: 2023-01-19
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.